Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Raj Denhoy
JEF
Raj Denhoy
Jefferies
Wall Street Analyst
★★★☆☆
#1679
on 13Foresight · ranked by our own returns
53%
Success Rate
+2.0%
Average Return
16 of 30 calls profitable · -11.0% vs benchmark
📈 Across the calls we could measure, roughly 53% of Raj Denhoy's ratings turned a profit when each position was held for 1 year — averaging +2.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

0 Buy 1 Hold 0 Sell
Raj's Stock Coverage 34 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
STAA
Staar Surgical
 Aug 06, 2025 HOLD Hold
+14.2% avg upside
16 analysts
$28.00
3.81% Downside
 +6.5%
ABT
Abbott Laboratories
 Oct 21, 2021 BUY Strong Buy
+31.2% avg upside
35 analysts
$145.00
63.99% Upside
 -22.7%
PODD
Insulet
 Oct 12, 2021 BUY Strong Buy
+79.0% avg upside
32 analysts
$340.00
133.27% Upside
 -21.8%
ESTA
Establishment Labs Holdings
 Aug 25, 2021 BUY Strong Buy
-1.6% avg upside
12 analysts
$90.00
6.04% Upside
 -7.6%
MDT
Medtronic
 Aug 25, 2021 BUY Buy
+23.5% avg upside
38 analysts
$155.00
95.36% Upside
 -29.8%
TFX
Teleflex
 Jun 02, 2021 BUY Buy
+42.1% avg upside
19 analysts
$485.00
281.94% Upside
 -25.1%
COO
Cooper Co
 May 24, 2021 BUY Buy
+102.3% avg upside
21 analysts
$450.00
582.78% Upside
 -13.5%
LIVN
LivaNova
 May 20, 2021 BUY Strong Buy
+0.2% avg upside
14 analysts
$105.00
33.70% Upside
 -21.3%
ZBH
Zimmer Biomet Holdings
 May 05, 2021 BUY Buy
+27.6% avg upside
37 analysts
$200.00
127.29% Upside
 -26.8%
EW
Edwards Lifesciences
 Apr 21, 2021 BUY Strong Buy
+11.7% avg upside
34 analysts
$110.00
25.95% Upside
 +31.9%
SYK
Stryker
 Jan 28, 2021 HOLD Strong Buy
+24.0% avg upside
36 analysts
$235.00
23.75% Downside
 +9.1%
HAE
Haemonetics
 Jan 21, 2021 BUY Buy
-9.2% avg upside
17 analysts
 — -58.4%
TSE:PRN
Profound Medical
 Sep 15, 2020 BUY Strong Buy
+96.1% avg upside
11 analysts
$31.00
222.82% Upside
 ·
AXGN
AxoGen
 Aug 05, 2020 BUY Strong Buy
-25.7% avg upside
21 analysts
$22.00
50.98% Downside
 +57.3%
DXCM
Dexcom
 Jul 29, 2020 BUY Strong Buy
+38.6% avg upside
32 analysts
$485.00
569.29% Upside
 +6.8%
BSX
Boston Scientific
 Jul 29, 2020 BUY Strong Buy
+72.9% avg upside
38 analysts
$46.00
1.55% Upside
 +13.8%
TELA
TELA Bio
 Jul 09, 2020 BUY Strong Buy
+1023.6% avg upside
8 analysts
$20.00
2396.81% Upside
 +17.6%
LNTH
Lantheus
 Jun 29, 2020 BUY Strong Buy
-27.9% avg upside
20 analysts
$29.00
72.16% Downside
 +96.4%
IL:KMDA
Kamada
 May 18, 2020 BUY Strong Buy
+77.2% avg upside
7 analysts
$2915.70
37.60% Upside
 ·
IART
Integra Lifesciences
 Oct 31, 2018 BUY Buy
+136.2% avg upside
21 analysts
$66.00
275.41% Upside
 +8.4%
OFIX
Orthofix Medical
 Aug 06, 2018 BUY Strong Buy
+207.1% avg upside
15 analysts
$69.00
630.16% Upside
 -14.4%
VREX
Varex Imaging
 Dec 21, 2017 BUY Strong Buy
+92.1% avg upside
9 analysts
$44.00
317.88% Upside
 -46.0%
MDWD
Mediwound
 Jul 20, 2017 BUY Strong Buy
+51.7% avg upside
13 analysts
$10.00
29.68% Downside
 -13.8%
LFWD
Lifeward
 May 04, 2017 BUY Strong Buy
+5.4% avg upside
8 analysts
$8.00
15.69% Upside
 -29.7%
ARAY
Accuray
 Apr 27, 2017 BUY Buy
+1689.3% avg upside
9 analysts
$7.00
1912.12% Upside
 +9.8%
ISRG
Intuitive Surgical
 Apr 24, 2017 BUY Strong Buy
+29.4% avg upside
36 analysts
$224.98
44.78% Downside
 +59.3%
UNH
UnitedHealth
 Aug 03, 2016 BUY Strong Buy
+2.3% avg upside
35 analysts
 — +38.6%
GB:SN
Smith & Nephew
 Aug 02, 2016 BUY Strong Buy
+1305.8% avg upside
15 analysts
$105766.59
9301.41% Upside
 ·
RMD
Resmed
 Jul 28, 2016 HOLD Buy
+25.4% avg upside
27 analysts
$60.00
68.24% Downside
 +20.2%
BDX
Becton Dickinson
 Feb 26, 2016 BUY Buy
+35.5% avg upside
25 analysts
$175.00
21.64% Upside
 +24.6%
QGEN
Qiagen
 Feb 15, 2016 HOLD Buy
+14.1% avg upside
23 analysts
$24.00
34.97% Downside
 +39.7%
MYGN
Myriad Genetics
 Feb 09, 2016 HOLD Hold
+313.3% avg upside
24 analysts
$38.00
737.06% Upside
 -53.3%
CYPH
Cypherpunk Technologies
 Aug 20, 2015 HOLD Buy
+1087.0% avg upside
9 analysts
$6.00
711.68% Upside
 ·
ATEC
Alphatec Holdings
 May 01, 2014 BUY Strong Buy
+112.9% avg upside
22 analysts
$2.00
77.24% Downside
 +4.4%
🔒 29 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Raj Denhoy — Frequently Asked Questions
How accurate are Raj Denhoy's stock ratings?
Based on the calls 13Foresight could measure, about 53% of Raj's ratings were profitable over a one-year hold, with an average return of +2.0% per rating, or -11.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Raj ranked on 13Foresight?
Raj Denhoy is currently ranked #1679 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Raj cover?
Raj most recently has ratings on STAA, ABT, PODD, ESTA, MDT, TFX, COO, LIVN, ZBH, EW, SYK, HAE and 22 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.